UBS Lux Equity Fund Biotech USD vs DNB Telecom S

UBS Lux Equity Fund Biotech USD vs DNB Telecom S

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

2. DNB Telecom S

  • Security

    DNB Telecom S

  • Fee

    1.20%

  • ISIN

    NO0012740192

  • Holdings

    13

Fund Holdings

We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with DNB Telecom S, we have 14 holdings where T-Mobile is the largest holding (9.47), followed by Deutsche Telekom (9.19) and KDDI Corp (7.51).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and DNB Telecom S.

UBS Lux Equity Fund Biotech USD DNB Telecom S
1. Regeneron Pharmaceuticals Inc
10.04 %
1. T-Mobile US Inc
USA
9.47 %
2. Moderna Inc
9.21 %
2. Deutsche Telekom AG
Germany
9.19 %
3. Gilead Sciences Inc
USA
4.66 %
3. KDDI Corp
Japan
7.51 %
4. BioNTech SE
4.13 %
4. Verizon Communications Inc
USA
5.25 %
5. Karuna Therapeutics Inc
3.75 %
5. Rogers Communications Inc
4.86 %
- 6. AT&T Inc
USA
4.52 %
- 7. Nokia Oyj
4.46 %
- 8. Nippon Telegraph & Telephone Corp
Japan
4.4 %
- 9. Telefónica SA
4.32 %
- 10. Elisa Oyj
Finland
4.19 %
- 11. Vodafone Group ADR
UK
3.86 %
- 12. Telenor ASA
Norway
3.69 %
- 13. SoftBank Corp
Japan
3.69 %

The list of fund holdings was last updated on September 10, 2025.